Emily Pimblett - CHIEF ACCOUNTING OFFICER at Eliem Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Stock Symbol
ELYM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Emily Pimblett - trading volume in the past year for Eliem Therapeutics, Inc.

Holdings reported by Emily Pimblett for Eliem Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 35K $253K $7.21 Jun 18, 2024 Direct Common Stock
Common Stock 3.76K $27.1K $7.21 Jun 20, 2024 Direct

Transactions reported by Emily Pimblett for Eliem Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.